Diagnosis of Wegener's granulomatosis in the ANCA era

Journal of Rheumatology

Volumn 33, Issue 10, 2006, Pages 1923-1924

  Al Maini, Mustafa ^a   Carette, Simon ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

AGRICULTURAL WORKER; ANTIBODY DETECTION; CLINICAL FEATURE; COCAINE DEPENDENCE; DIAGNOSTIC VALUE; EDITORIAL; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC PREDISPOSITION; HUMAN; IMMUNOFLUORESCENCE; INCIDENCE; INFECTION; NASAL BIOPSY; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RISK FACTOR; WEGENER GRANULOMATOSIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; FEMALE; HUMANS; INCIDENCE; MALE; MYELOBLASTIN; PANCREATIC ELASTASE; PEROXIDASE; SWEDEN; WEGENER GRANULOMATOSIS;

EID: 33750004357     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (15)

1. Borgmann S, Haubitz M. Genetic impact of pathogenesis and prognosis of ANCA-associated vasculitides. Clin Exp Rheumatol 2004;22 Suppl 36:S79-S86.
2. Lane SE, Watts RA, Bentham G, Innes NJ, Scott DGI. Are environmental factors important in primary systemic vasculitis. Arthritis Rheum 2003;48:814-23.
3. Albert D, Clarkin C, Komoroski J, Brensinger CM, Berlin JA. Wegener's granulomatosis: Possible role of environmental agents in its pathogenesis. Arthritis Rheum 2004;51:656-64.
4. Albert DA, Albert AN, Vernace M, Sebastian JK, Hsia EC. Analysis of a cluster of cases of Wegener's granulomatosis. J Clin Rheumatol 2005;11:188-93.
5. Koldingsnes W, Nossent H. Epidemiology of Wegener's granulomatosis in northen Norway. Arthritis Rheum 2000;43:2481-7.
6. Watts RA, Lane SE, Bentham G, Scott DG. Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum 2000;43:414-9.
7. Gibson A, Stamp LK, Chapman PT, O'Donnell JL. The epidemiology of Wegener's granulomatosis and microscopic polyangiitis in a Southern Hemisphere region. Rheumatology Oxford 2006;45:624-8.
8. Gonzalez-Gay MA, Garcia-Porrua C, Guerrero J, Rodriguez-Ledo P, Llorca J. The epidemiology of the primary systemic vasculitides in Northwest Spain: Implications of the Chapel Hill Consensus Conference definitions. Arthritis Rheum 2003;49:388-93.
9. Knight A, Ekbom A, Brandt L, Askling J. Increasing incidence of Wegener's granulomatosis in Sweden 1975-2001. J Rheumatol 2006;33:2060-3.
10. Davies DJ, Moran JE, Niall JF, Ryan GB. Segmental necrotizing glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? Br Med J (Clin Res Ed) 1982;285:606.
11. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:122-9.
12. Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gross WL. Stable incidence of primary systemic vasculitides over five years: Results from the German Vasculitis Register. Arthritis Rheum 2005;53:93-9.
13. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98:76-85.
14. Duna GF, Galperin C, Hoffman D. Wegener's granulomatosis. Rheum Dis Clin North Am 1995;21:949-86.
15. Wiesner O, Russell KA, Lee AS, et al. Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis. Arthritis Rheum 2004;50:2954-65.